NHAS
Novo Holdings A/S Portfolio holdings
AUM
$1.42B
1-Year Return
12.08%
This Quarter Return
+11.12%
1 Year Return
+12.08%
3 Year Return
+99.82%
5 Year Return
+98.46%
10 Year Return
+612.59%
AUM
$1.52B
AUM Growth
-$86M
(-5.4%)
Cap. Flow
-$324M
Cap. Flow
% of AUM
-21.4%
Top 10 Holdings %
Top 10 Hldgs %
55.26%
Holding
50
New
2
Increased
13
Reduced
10
Closed
3
Top Buys
| 1 |
LanzaTech
LNZA
|
$61.4M |
| 2 |
4D Molecular Therapeutics
FDMT
|
$12M |
| 3 |
Insmed
INSM
|
$8.51M |
| 4 |
Crinetics Pharmaceuticals
CRNX
|
$5.83M |
| 5 |
SPRB
Spruce Biosciences, Inc. Common Stock
SPRB
|
$4.88M |
Top Sells
| 1 |
Stryker
SYK
|
$195M |
| 2 |
Steris
STE
|
$86.4M |
| 3 |
Boston Scientific
BSX
|
$62.6M |
| 4 |
CTLT
CATALENT, INC.
CTLT
|
$52.6M |
| 5 |
SGEN
Seagen Inc. Common Stock
SGEN
|
$15.2M |
Sector Composition
| 1 | Healthcare | 57.28% |
| 2 | Technology | 25.52% |
| 3 | Financials | 5.42% |
| 4 | Communication Services | 4.36% |
| 5 | Industrials | 4.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
VERV
26
DELISTED
Verve Therapeutics
VERV
| $17.3M | 1.14% |
1,200,000
+288,889
| +32% | +$4.17M |
|
|
DICE
27
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $16.7M | 1.1% |
536,100
+71,100
| +15% | +$2.22M |
|
28
Rocket Pharmaceuticals
RCKT
$354M
| $15.8M | 1.04% |
920,000
+70,000
| +8% | +$1.2M |
|
|
BLU
29
DELISTED
BELLUS Health Inc.
BLU
| $15.4M | 1.02% |
2,137,975
+439,891
| +26% | +$3.17M |
|
|
SPRB
30
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| $14.9M | 0.98% |
6,722,336
+2,208,000
| +49% | +$4.88M |
|
31
Inspire Medical Systems
INSP
$2.56B
| $14M | 0.93% |
60,000
-3,304
| -5% | -$773K |
|
32
Treace Medical Concepts
TMCI
$453M
| $13.6M | 0.9% |
540,000
-97,317
| -15% | -$2.45M |
|
33
Rallybio
RLYB
$25.4M
| $13M | 0.86% |
2,270,110
-25,897
| -1% | -$148K |
|
|
34
4D Molecular Therapeutics
FDMT
$340M
| $12M | 0.79% |
+700,000
| New | +$12M |
|
|
NARI
35
DELISTED
Inari Medical, Inc. Common Stock
NARI
| $11.1M | 0.73% |
180,000
-60,800
| -25% | -$3.75M |
|
|
SILK
36
DELISTED
Silk Road Medical, Inc. Common Stock
SILK
| $10.8M | 0.71% |
275,511
| – | – |
|
37
Pharvaris
PHVS
$1.48B
| $10.7M | 0.71% |
1,329,325
+142,018
| +12% | +$1.14M |
|
38
AbCellera Biologics
ABCL
$1.26B
| $8.5M | 0.56% |
1,126,915
| – | – |
|
|
GRTX
39
DELISTED
Galera Therapeutics, Inc. Common Stock
GRTX
| $6.3M | 0.42% |
2,459,021
| – | – |
|
40
IO Biotech
IOBT
$128M
| $6.15M | 0.41% |
3,277,932
| – | – |
|
41
Pulmonx
LUNG
$70.9M
| $5.71M | 0.38% |
510,555
| – | – |
|
|
KNTE
42
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
| $5.1M | 0.34% |
815,707
| – | – |
|
43
LAVA Therapeutics
LVTX
$41.3M
| $5.1M | 0.34% |
3,070,558
-256,754
| -8% | -$426K |
|
44
Galecto
GLTO
$3.99M
| $4.97M | 0.33% |
99,912
| – | – |
|
45
Marqeta
MQ
$2.76B
| $2.02M | 0.13% |
441,558
| – | – |
|
46
Kezar Life Sciences
KZR
$29.8M
| $1.46M | 0.1% |
46,560
-70,940
| -60% | -$2.22M |
|
47
Spero Therapeutics
SPRO
$121M
| $680K | 0.04% |
468,902
| – | – |
|
|
48
Boston Scientific
BSX
$159B
| – | – |
-1,353,081
| Closed | -$62.6M |
|
|
49
Steris
STE
$24.2B
| – | – |
-467,687
| Closed | -$86.4M |
|
|
50
Stryker
SYK
$150B
| – | – |
-796,941
| Closed | -$195M |
|